BioSpace News Archive

Consumer Ratings for In-Home Care Services Determine “Caring Stars of 2019"

Net Proceeds of $1.1 Million in Non-dilutive Funding Expected

BioLineRx Ltd. announced today that it will host an investor breakfast meeting on Tuesday, December 11, 2018 at the Convene Conference Center near Grand Central Terminal in New York, N.Y.

Inari Medical, Inc. announced today the enrollment of the first patient in the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (“FLASH”) using the FlowTriever® System for the treatment of pulmonary embolism (PE).

Transaction brings together world’s most technologically advanced vaporizer company and world’s leading cannabis company

Grants rights to research, develop and commercialize antibodies generated using the AlivaMab Mouse platform

- Novel gene therapy for patients with treatment-resistant angina who have no remaining treatment options is ready to enter clinical development -

Accuray Incorporated (NASDAQ: ARAY) announced today that the new release of its Accuray Precision® Treatment Planning System (TPS) with the CyberKnife® VOLO™ Optimizer will enable CyberKnife System customers to significantly improve operational efficiency by reducing both the time to create high quality treatment plans and the time it takes to deliver patient treatments.

Novocure (NASDAQ:NVCR) announced today that the results of a retrospective post-hoc sub-group analysis of its EF-14 phase 3 pivotal trial in newly diagnosed glioblastoma (GBM) have been published in the Journal of Neuro-Oncology.

Function meets Fashion with Hybrid Wellness Watch